O Serviço de Imunoalergologia desenvolve atividade científica em coloração com Clínica Universitária de Imunoalergologia, Faculdade de Medicina da Universidade de Lisboa (FMUL), conta com 3 doutorados (Professores Manuel Branco Ferreira, Susana Lopes da Siva e Joana caiado) e 1 estudante de doutoramento (Joana Cosme). O Prof. Doutor Manuel Branco Ferreira é o atual Diretor da Clínica Universitária de Imunoalergologia e regente da cadeira de Imunoalergologia desta mesma faculdade. A atividade laboratorial de investigação na área de imunoalergologia desenvolve-se no Laboratório de Imunologia Clínica da FMUL/GIMM/CAML e é coordenada Profª. Doutora Susana Lopes da Silva.
As principais áreas de investigação científica do serviço são: alergia respiratória, alergénios e imunoterapia com alergénios, alergia a veneno de himenópteros, alergia alimentar e fármacos, angioedema hereditário, eczema atópico, esofagite eosinofílica, urticária e imunodeficiências primárias.
O Serviço conta com a colaboração do Centro de Investigação Clínica da FMUL/CAML em alguns projetos de investigação.
Projetos a decorrer no Serviço de Imunoalergologia
(Informação atualizada em maio 2025)
- MT-7117-C-201 study. A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MT-7117 in Patients with Solar Urticaria
- CLOU064M12301 study. A 52-week multi-center, randomized, double-blind, placebo controlled, basket study with an open-label extension to investigate the efficacy, safety, and tolerability of remibrutinib (LOU064) in Chronic Inducible Urticaria (CINDU) in adults inadequately controlled by H1-antihistamines.
- CDX0159-12 study. A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab in Patients with Chronic Spontaneous Urticaria Who Remain Symptomatic Despite H1 Antihistamine Treatment (EMBARQ – CSU1). Short Title: A Phase 3 Study of Barzolvolimab in Patients with Chronic Spontaneous Urticaria (EMBARQ – CSU1)
- AlergoPortugal 2024. Estudo epidemiológico das doenças Imunoalérgicas em Portugal.
- MM09-SIT-063 study. EU CT Nº: 2023-508547-51-00. Prospective, randomised, double-blind, placebo-controlled multicenter clinical trial of efficacy and safety with Dermatophagoides pteronyssinus and Dermatophagoides farinae mannan-conjugated allergoids in patients with rhinitis/rhinoconjunctivitis, allergic to Dermatophagoides pteronyssinus and/or Dermatophagoides farinae.
- Mavorixafor (X4P-001-110) study. A Phase 3, randomized, double-blind, placebo-controlled, multicenter study of mavorixafor in participants with congenital and acquired primary autoimmune and idiopathic chronic neutropenic disorders who are experiencing recurrent and/or serious infections.
- NIMBLE study. A 52-week, randomised, double-blind, double-dummy, parallel group, multi-centre, non-inferiority study assessing exacerbation rate, additional measures of asthma control and safety in adult and adolescent severe asthmatic participants with an eosinophilic phenotype treated with GSK3511294, compared with mepolizumab or benralizumab.
- LOGOS study. A Randomized, Double-Blind, Double Dummy, Parallel Group, Multicenter 24 to 52 Week Variable Length Study to Assess the Efficacy and Safety of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered Dose Inhaler (MDI) Relative to Budesonide and Formoterol Fumarate MDI and Symbicort® pMDI in Adult and Adolescent Participants with Inadequately Controlled Asthma.
Da atividade científica desenvolvida pelo Serviço de Imunoalergologia/Clínica Universitária de Imunoalergologia resultam várias publicações em revistas nacionais e internacionais.
Publicações do Serviço de Imunoalergologia
(Informação atualizada em dezembro 2024)
2024
- Madeira Gerardo A, da Silva Alves C, Gomes M, Pardal C, Sokolova A, Liberato H, Mendes A, Tonin FS, Duarte-Ramos F, Lopes C. The Effects of Benralizumab on Lung Volumes and Airway Resistance in Severe Eosinophilic Asthma: A Real-World Study. 2024 Jan 17;16(1):e52452. doi: 10.7759/cureus.52452.
- Ferreira SC, Vieira J, Silva MI, Caiado J, Pedro E, Silva S. Terapêutica Substitutiva com Imunoglobulina G Polivalente: Particularidades de um Coorte Português. Acta Med Port 2024 Apr;37(4):239-242 https://doi.org/10.20344/amp.20677.
- Penedos C, Salamanca, G, Tavares, B, Fonseca, J, Carreiro Martins, P, Rodrigues-Alves R, Moral de Gregório Á, Valero A Branco Ferreira M. Aerobiology of Olive Pollen (Olea europaea L.) in the Atmosphere of the Iberian Peninsula. Atmosphere 2024, 15, 1087. https:// org/10.3390/atmos15091087
- Camacho I, Caeiro E, Camacho R, Grinn-Gofroń A, Strzelczak A, Ferreira MB, Carreiro-Martins P. To what extent can wildfires in the Mediterranean influence pollen abundance? Allergy 2024 Aug;79(8):2287-2289. doi: 10.1111/all.16211.
- Vieira J, Cosme J, Costa C, Alonso E, Pedro P, Spínola Santos A, Branco Ferreira M. Dados de vida real no angioedema hereditário – Uma série portuguesa de crianças e adolescentes. Rev Port Imunoalergologia 2024;32(10):1-11. http://dx.doi.org/10.32932/rpia.2024.07.142
- Cosme J, Pedro E, Pereira-Santos MC, Lopes A, Caiado J, Paulino M et al. Molecular sensitization profile to grass and olive pollens in Portugal. Eur Ann Allergy Clin Immunol. 2024 Jun 24. doi: 10.23822/EurAnnACI.1764-1489.347. Epub ahead of print. PMID: 38913398.
- Ferreira SC, Gomes M, Vieira J, Caldeira L, Silva MI, Ferreira MB, Pedro E, Cosme J. Managing systemic reactions and venom immunotherapy in vespid-venom allergy: observations from a retrospective study of Portuguese patients. Eur Ann Allergy Clin Immunol. 2024 Jun 26. doi: 10.23822/EurAnnACI.1764-1489.349. Epub ahead of print. PMID: 38919151.
- Esteves Caldeira L, Limão R, Brás R, Pedro E, Costa C. A real-world characterization of a population with eosinophilic esophagitis: looking for severity biomarkers. Eur Ann Allergy Clin Immunol (2024);56(6):252-262. doi: 10.23822/EurAnnACI.1764-1489.292
- Silva MI, Brás R, Paulino M, Duarte FC, Pereira-Santos MC, Costa C. Clinical characterization of peach allergic patients and respective molecular sensitization profile with ALEX®2 macroarray. Eur Ann Allergy Clin Immunol. 2024;56(4):188-91
2023
- Esteves Caldeira L, Paulino M, Coutinho C, Neto M, Costa C, Pereira Barbosa M. Clinical Experience of a Specialized Urticaria Consultation from a UCARE Center. Eur Ann Allergy Clin Immunol. 2023 Jan;55(1):9-18. https://doi.org/10.23822/EurAnnACI.1764-1489.209.
- Limão R, Brás R, Neto M, Fernandes RA, Lopes Abreu C, Costa C, Cosme J, Duarte F, Mendes A, Spínola Santos A, Branco Ferreira M, Pedro E, Lopes A. Controlo a longo prazo da dermatite atópica em doentes sob terapêutica com dupilumab – um estudo multicêntrico. Rev Port Imunoalergologia 2023;31(1):31-43. http://doi.org/10.32932/rpia.2023.03.101.
- Silva MI, Paulino M, Cabral Duarte F, Pedro E, Costa C. Safety of 2-days protocol in sublingual immunotherapy with pru p 3. Explor Asthma Allergy, 2023;1:142-152. https://doi.org/10.37349/eaa.2023.00015.
- Gomes AMC, Farias GB, Trombetta AC, Godinho-Santos A, Parreira I, Gonçalves HD, Simões ML, Aguiar P, Deveza MM, Inácio J, Sousa AE, da Silva SL. (2023) Phenotype of BTK-lacking myeloid cells during prolonged COVID-19 and upon convalescent plasma. Eur J Haematol. 2023;110(2):209-212. doi: 10.1111/ejh.13881.
- Silva MIT, Varandas C, Ferreira S, Duarte FC. Gadolinium-Derived Contrast Agents Hypersensitivity: Retrospective Characterization of a Portuguese Cohort. Acta Radiológica Portuguesa 2023;35(2);4-8. http://doi.org/10.25748/arp.29707.
- Varandas C, Presa AR, Duarte Ferreira R, Pereira Silva S, Lopes da Silva S. Infeção por SARS-CoV-2 nos doentes com Agamaglobulinémia ligada ao X. Rev Port Imunoalergologia, 2023; 31 (3): 217-226. http://doi.org/10.32932/rpia.2023.08.117.
- Presa AR, Varandas C, Esteves Caldeira L, Duarte Ferreira R, Marques T, Pereira Silva S, Gonçalo Marques J, Lopes da Silva S. Doença granulomatosa crónica no adulto: evolução clínica e opções terapêuticas. Rev Port Imunoalergologia, 2023; 31 (2): 103-107. http://doi.org/10.32932/rpia.2023.06.113.
- Bernardino A, Costa C, Silva MI, Mendes A, Spínola Santos A, Lopes Silva S, Neto M, Pedro E. Autoadministração de Omalizumab na Urticária Crónica Espontânea– Estudo Observacional num Centro Ucare. Rev Port Imunoalergologia. 2023; 31 (2): 123-135 http://doi.org/10.32932/rpia.2023.04.109.
- Couto S, Silva S, Costa C, Silva SL. Hiperplasia nodular linfóide no intestino em adultos com Imunodeficiência comum variável. Rev Port Imunoalergologia 2023; 31 (2): 169-170. http://doi.org/10.32932/rpia.2023.06.115.
- Gomes M, Mendes A, Ferreira F, Branco J, Tonin FS, Pedro ME. The role of benralizumab in eosinophilic immune dysfunctions: A case report-based literature review. Case Rep Med 2023 Apr 24;2023:8832242. doi:10.1155/2023/8832242.
- Paulino M, Costa C. The Challenge of omalizumab refractory chronic spontaneous urticaria and the relevance of suspecting Schnitzler syndrome without monoclonal gammopathy. Rev Port Imunoalergologia 2023;31(3):227-232. http://doi.org/10.32932/rpia.2023.08.119.
- Pessoa VC, Branco Ferreira M, Jonsdottir S, Marti E, Tilley P. Comparison of skin prick tests (SPT), intradermal tests (IDT) and in vitro tests in the characterization of insect bit hypersensitivity (IBH) in a population of Lusitano horses: contribution for future implementation of SPT in IBH diagnosis. Animal (Basel) 2023;13(17):2733. https://doi.org/10.3390/ani13172733.
- Branco Ferreira M, Baeza ML, Spinola Santos A, Prieto-Garcia A, Leal R, Alvarez J, Caballero TJ. Evolution of guidelines for the management of hereditary angioedema due to C1-inhibitor deficiency. J Investig Allergol Clin Immunol 2023;33(5):332-62. https://org/10.18176/jiaci.0909.
- Marques J, Duarte-Ramos F, Branco Ferreira M, Lima R, Lopes C, Sokolova A, Tonin FS, Loureiro CC; Portuguese ROSA group. Optimizing the use of systemic corticosteroids in severe astham (ROSA II project): a national Delphi consensus study. Pulmonology 2023;29(6):555-63. https://doi.org/10.1016/j.pulmoe.2023.07.003.
- Bernardino AG, Ferreira MB, Costa C, Caiado J, Pedro E, Santos AS. Experience of lanadelumab administration in hereditary angioedema: A case series of 4 patients in Portugal. Asia Pac Allergy. 2023 Jun;13(2):91-94. doi:10.5415/apallergy.0000000000000102.
- Brás R, Caiado J, Pedro E. Rapid Desensitization to Acetylsalicylic Acid in patients with ischemic heart disease: 10-year experience of a Portuguese Allergy Department. Eur Ann Allergy Clin Immunol, 2023; 55(4):166-173. doi: 10.23822/EurAnnACI.1764-1489.230.
- Brás R, Costa C, Limão R, Esteves-Caldeira L, Paulino M, Pedro E. Omalizumab in CSU: Real-life experience in doses/intervals adjustments and treatment discontinuation. J Allergy Clin Immunol Pract, 2023;11(8):2392-2402. doi: 10.1016/j.jaip.2023.01.022.
- Brás R, Esteves Caldeira L, Bernardino A, Costa C. Anti-TPO/Total IgE ratio: Biomarker for Omalizumab response prediction in Chronic Spontaneous Urticaria. Int Arch Allergy Immunol, 2023; 184 (9): 866–869. doi: 10.1159/000532021.
- Sousa e Silva R, Silva SP, Luís R, Baldaia C, Silva SL. Nodular regenerative hyperplasia in CVID patients: could low-dose oral glucocorticoids be part of the solution? Eur Ann Allergy Clin Immunol. 2023; 55(6):313-315. doi:10.23822/EurAnnACI.1764-1489.251.
- Brás RJ, Cosme J, Brás R, Pedro E; Spínola-Santos A. Segurança da vacinação contra a COVID-19 em doentes referenciados dos cuidados de saúde primários por alergia ao veneno de himenópteros. Arq Asma Alerg Imunol, 2023; 7 (2): 201-208. http://dx.doi.org/10.5935/2526-5393.20230026.
- Brás R, Bartolomé B, Pedro E, Costa C. Sensitisation to poultry meat, fish and coconut in a multiple food allergic young boy. Arq Asma Alerg Imunol, 2023; 7(3): 302-306. doi.5935/2526-5393.20230044-en.
- Esteves Caldeira L, Brás R, Varandas C, Cabral Duarte F, Costa C. Tree Nut and Peanut Allergy in a Portuguese Pediatric Cohort – Clinical Characterization and Anaphylaxis Predictors. Prog Asp in Pediatric & Neonat 4(4)- 2023. PAPN. MS.ID.000193. https://doi.org/10.32474/PAPN.2023.04.000193.
- Torres-Valle A, Aragon L, Silva SL, Serrano C, Marcos M, Melero J, Bonroy C, Arenas-Caro PP, Casado DM, Olaizola PMR, Neirinck J, Hofmans M, de Arriba S, Jara M, Prieto C, Sousa AE, Prada Á, van Dongen JJM, Pérez-Andrés M, Orfao A. In-depth blood immune profiling of Good syndrome patients. Front Immunol 2023 Nov 15:14:1285088. doi: 10.3389/fimmu.2023.1285088.
- Esteves Caldeira L, Bernardino A, Paulino M, Costa C. Four-week total IgE/baseline total IgE ratio: Biomarker for omalizumab good response in chronic spontaneous urticaria real-life patients. J Allergy Clin Immunol Pract. 2023 Dec;11(12):3808-3811. doi: 10.1016/j.jaip.2023.09.010.
- Varandas C, Vieira J, Correia CJ, Paulino M, Spínola Santos A, Lopes A, Lopes Da Silva S, Pedro E, Caiado J. Hypersensitivity reactions to iron products: 10-year experience in a Portuguese tertiary Centre. Eur Ann Allergy Clin Immunol, 2023. doi:10.23822/EurAnnACI.1764-1489.290. Online ahead of print.
- Esteves Caldeira L, Limão R, Brás R, Pedro E, Costa C. A real-world characterization of a cohort with eosinophilic esophagitis: looking for severity biomarkers. Eur Ann Allergy Clin Immunol. 2023. https://doi.org/ 10.23822/EurAnnACI.1764-1489.292. Online ahead of print.
- Silva MI, Brás R, Paulino M, Cabral Duarte F, Pereira Santos MC, Costa C. Clinical characterization of peach allergic patients and respective molecular sensitization profile with ALEX®2 macroarray. Eur Ann Allergy Clin Immunol. 2023 Feb 14. doi:10.23822/EurAnnACI.1764-1489.284.Online ahead of print.
- Silva MI, Cosme J, Lorenzo C, Virtuoso J, Gomes R, Pedro E, Neves AM, Lopes A. Hypersensitivity to Non-Steroidal Anti-Inflammatory Drugs on a pediatric Portuguese cohort. Eur Ann Allergy Clin Immunol. 2023 May 30.doi:10.23822/EurAnnACI.1764-1489.299. Online ahead of print.
2022
- Bizjak M, Košnik M, Dinevski D, Thomsen SF, Fomina D, Borzova E, Kulthanan K, Meshkova R, Aarestrup FM, Ahsan DM, Al-Ahmad M, Altrichter S, Bauer A, Brockstädt M, Costa C, Demir S, Criado RF, Ensina LF, Gelincik A, Giménez-Arnau AM, Gonçalo M, Gotua M, Holm JG, Inomata N, Kasperska-Zajac A, Khoshkhui M, Klyucharova A, Kocatürk E, Lu R, Makris M, Maltseva N, Pasali M, Paulino M, Pesqué D, Peter J, Ramón GD, Ritchie C, Rodrigues Valle SO, Rudenko M, Sikora A, Wagner N, Xepapadaki P, Xue X, Zhao Z, Terhorst-Molawi D, Maurer M. Adrenaline autoinjector is underprescribed in typical cold urticaria patients. Allergy. 2022 Jul;77(7):2224-2229. doi: 10.1111/all.15274. Epub 2022 Mar 14. PMID: 35258111.
- Bizjak M, Košnik M, Dinevski D, Francis Thomsen S, Fomina D, Borzova E, Kulthanan K, Meshkova R, Aarestrup F, Melina Ahsan D, Al-Ahmad M, Altrichter S, Bauer A, Brockstädt M, Costa C, Demir S, Fachini Criado R, Felipe Ensina L, Gelincik A, Giménez-Arnau AM, Gonçalo M, Gotua M, Grønlund Holm J, Inomata N, Kasperska-Zajac A, Khoshkhui M, Klyucharova A, Kocatürk E, Lu R, Makris M, Maltseva N, Pasali M, Paulino M, Pesqué D, Peter J, Dario Ramón G, Ritchie C, Oliveira Rodrigues Valle S, Rudenko M, Sikora A, Wagner N, Xepapadaki P, Xue X, Zhao Z, Terhorst-Molawi D, Maurer M. Adrenaline autoinjector is under-prescribed in typical cold urticaria patients living in tropical climate countries. Qatar Med J. 2022 Mar 24;2022(2):19. doi: 10.5339/qmj.2022.fqac.19. PMID: 35909392; PMCID: PMC9284591.
- Bizjak M, Košnik M, Dinevski D, Thomsen SF, Fomina D, Borzova E, Kulthanan K, Meshkova R, Ahsan DM, Al-Ahmad M, Altrichter S, Bauer A, Brockstädt M, Costa C, Demir S, Fachini Criado R, Ensina LF, Gelincik A, Giménez-Arnau AM, Gonçalo M, Gotua M, Holm JG, Inomata N, Kasperska-Zajac A, Khoshkhui M, Klyucharova A, Kocatürk E, Lu R, Makris M, Maltseva N, Miljković J, Pasali M, Paulino M, Pesqué D, Peter J, Ramón GD, Ritchie C, Rodrigues Valle SO, Rudenko M, Sikora A, de Souza Lima EM, Wagner N, Xepapadaki P, Xue X, Zhao Z, Terhorst-Molawi D, Maurer M. Risk factors for systemic reactions in typical cold urticaria: Results from the COLD-CE study. Allergy. 2022 Jul;77(7):2185-2199. doi: 10.1111/all.15194. Epub 2021 Dec 23. PMID: 34862605.
- Varandas C, Esteves Caldeira L, Silva SL, Costa C, Limão R, Silva MI, Lopes A, Caiado J, Cosme J, Alonso E, Marcelino J, Cabral Duarte F, Fernandes NP, Neto M, Pedro E, Branco Ferreira M, Spínola Santos A. Hereditary angioedema: 24 years of experience in a Portuguese reference center. Eur Ann Allergy Clin Immunol. 2024 Sep;56(5):210-218. doi: 10.23822/EurAnnACI.1764-1489.278. Epub 2022 Dec 14. PMID: 36515257.
- Coutinho C, Lourenço T, Fernandes M, Neto M, Lopes A, Spínola Santos A, Pereira Barbosa M. Subcutaneous immunotherapy with aeroallergens: safety profile assessment. Eur Ann Allergy Clin Immunol. 2022;54(2):77-83.DOI: 10.23822/EurAnnACI.1764-1489.194.
- Limão R, Spínola Santos A, Araújo L, Cosme J, Inácio F, Tomaz E, Ferrão A, Santos N, Sokolova A, Môrete A, Falcão H, Cunha L, Ferreira A, Brás A, Ribeiro F, Lozoya C, Leiria Pinto P, Prates S, Plácido J, Coimbra A, Taborda-Barata L, Pereira Santos MC, Pereira Barbosa M, Pineda F. Molecular Profile of Sensitization to Dermatophagoides pteronyssinus Dust Mite in Portugal. Journal of Investigational Allergology and Clinical Immunology. 2022; 32(1):33-39. DOI: 10.18176/jiaci.0533.
- Varandas C, Pereira-Santos MC, Neto M et al. Serum IL-22 binding protein as a marker for atopic dermatitis activity and response to dupilumab treatment. Clin Exp Allergy. 2022;10.1111/cea.14147. DOI: 10.1111/cea.14147
- Sousa e Silva R, Pereira da Silva S, Luís R, Baldaia C, Lopes da Silva S. Nodular regenerative hyperplasia in CVID patients: could low-dose oralglucocorticoids be part of the solution? Eur Ann Allergy Clin Immunol. 2022 Mar 18. Online ahead of print. doi: 10.23822/EurAnnACI.1764-1489.251.
- Motta-Raymundo A, Rosmaninho P, Santos DF, Ferreira RD, Silva SP, Ferreira C, Sousa AE, Silva SL. Contribution of Helicobacter pylori to the Inflammatory Complications of Common Variable Immunodeficiency. Front Immunol. 13:834137. eCollection 2022. doi: 10.3389/fimmu.2022.834137.
- Filipa Ribeiro, Vasco C Romão, Sara Rosa, Kátia Jesus, Ana Água-Doce, Sofia C Barreira, Patrícia Martins, Susana Lopes da Silva, Ema Nobre, Maria João Bugalho, Válter R Fonseca, João Eurico Fonseca, Luis Graça. Different antibody-associated autoimmune diseases have distinct patterns of T follicular cell dysregulation. Sci Rep (2022);12(1):17638. doi: 10.1038/s41598-022-21576-8.
- Gomes AMC, Farias GB, Trombetta AC, Godinho-Santos A, Parreira I, Gonçalves HD, Simões ML, Aguiar P, Deveza MM, Inácio J, Sousa AE, Silva SL. Phenotype of BTK-lacking myeloid cells during prolonged COVID-19 and upon convalescent plasma. Eur J Haematol. 2022 Oct 8. Online ahead of print. doi: 10.1111/ejh.13881.
- Ensina LF, Ki Min T, Félix MMR, Tavares de Alcântara C, Costa C. Acute Urticaria and Anaphylaxis: Differences and Similarities in Clinical management. Allergy, 15 Apr 2022. doi.org/10.3389/falgy.2022.840999.
- Varandas C, Pereira-Santos MC, Neto M et al. Serum IL-22 binding protein as a marker for atopic dermatitis activity and response to dupilumab treatment. Clin Exp Allergy. 2022;10.1111/cea.14147. doi:10.1111/cea.14147
- Ramos AL, Varandas C, Cabrita H, et al. Comparison of two spirometry reference equations in predicted FEV1quantification and its effects on hematopoietic cell transplantation-specific comorbidity index (HCT-CI). Health Sci Rep. 2022;5(4):e707. doi:10.1002/hsr2.707
- Costa C, Rosmaninho I; Portuguese Study Investigational Group. Chronic urticaria in the real-life clinical practice setting in Portugal: 2-years results from the non-interventional multicenter AWARE study. Acta Med Port. 2022 Jan 3;35(1):12-19. DOI: 10.20344/amp.14477.
- Brás R, Limão R, Esteves Caldeira L, Lopes A, Mendes A, Coutinho C, Costa C, Alonso E, Duarte F, Caiado J, Cosme J, Paulino M, Neto M, Fernandes N, Silva S, Lopes da Silva S, Pedro E, Spínola Santos A. Impacto da Alergia Medicamentosa na Avaliação do Risco de Anafilaxia na Vacinação COVID-19: Experiência de um Serviço de Imunoalergologia. Rev Port Imunoalergologia 2022;30(3):191-206. DOI: 10.32932/rpia.2022.09.087.
- Alen Coutinho I, Luís Marques M, Carneiro-Leão L, Santos N, Castro Neves A, Gapar A, Spínola Santos A, Branco Ferreira M. Anafilaxia e Doenças Imunoalérgicas da SPAIC – Sociedade Portuguesa de Alergologia e Imunologia Clínica. Angioedema: Abordagem Diagnóstica e Terapêutica em Contexto de Urgência [Angioedema: Diagnostic and Therapeutic Approach in the Emergency Department]. Acta Med Port. 2022 Apr 1;35(4):307-309. Portuguese. doi: 10.20344/amp.17506.
- Caeiro E, Almeida J, Carreiro-Martins P, Tavares B, Fonseca J, Rodrigues-Alves R, Ferreira MB. Análise aerobiológica e alergénica do pólen de Amaranthaceae na Região do Alentejo (Sul de Portugal). Rev Port Imunoalergologia 2022; 30(4):287-298. DOI: 10.32932/rpia.2022.12.097.
- Varandas C, Valente C, Martins-dos-Santos G, Sangalho I, Marques ML, Rama TA, Pereira AM. Rinite não-alérgica. Rev Port Imunoalergologia. 2022; 30(4):300-309. DOI: 10.32932/rpia.2022.12.094.
- Varandas C, Nunes IG, Esteves-Caldeira L, Silva MI, Pereira AM. Rinossinusite aguda. Rev Port Imunoalergologia 2022;30(1): 121-9. DOI: 10.32932/rpia.2022.06.083
- Gonçalo M, Costa C. GPEU – Grupo Português de Estudos de Urticária. Questionnaire recommended by the Portuguese Group of Urticaria Studies (GPEU) for the evaluation of patients with Chronic Urticaria in an outpatient clinic. Rev Port Imunoalergologia 2022; 30 (1): 43-49.Doi: https://doi.org/10.32932/rpia.2022.03.077
